HPGC Renmintongtai Pharmaceutical Corp (600829) — Financial Flexibility Index
HPGC Renmintongtai Pharmaceutical Corp (600829) has a Financial Flexibility Index of -0.04x as of September 2025. Free cash flow of CN¥-180.70 Million (operating CF CN¥-187.38 Million minus capex CN¥6.68 Million) represents 0% of total liabilities (CN¥4.03 Billion). Check 600829 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
HPGC Renmintongtai Pharmaceutical Corp Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for HPGC Renmintongtai Pharmaceutical Corp across 28 annual periods. See HPGC Renmintongtai Pharmaceutical Corp working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for HPGC Renmintongtai Pharmaceutical Corp (1998–2025)
Year-by-year free cash flow to debt coverage for HPGC Renmintongtai Pharmaceutical Corp. For the full company profile including market capitalisation, see how much is HPGC Renmintongtai Pharmaceutical Corp worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.08x | CN¥317.13 Million | CN¥299.98 Million | CN¥4.16 Billion | ▲ +164.6% |
| 2024 | 0.03x | CN¥123.48 Million | CN¥115.44 Million | CN¥4.29 Billion | ▼ -62.2% |
| 2023 | 0.08x | CN¥356.47 Million | CN¥332.99 Million | CN¥4.68 Billion | ▲ +11.7% |
| 2022 | 0.07x | CN¥313.75 Million | CN¥307.33 Million | CN¥4.60 Billion | ▲ +240.7% |
| 2021 | -0.05x | CN¥-220.76 Million | CN¥-233.00 Million | CN¥4.55 Billion | ▼ -4192.9% |
| 2020 | 0.00x | CN¥4.75 Million | CN¥-9.22 Million | CN¥4.00 Billion | ▲ +101.1% |
| 2019 | -0.11x | CN¥-403.27 Million | CN¥-411.60 Million | CN¥3.70 Billion | ▼ -182.9% |
| 2018 | 0.13x | CN¥372.19 Million | CN¥366.45 Million | CN¥2.83 Billion | ▲ +190.3% |
| 2017 | 0.05x | CN¥146.17 Million | CN¥139.07 Million | CN¥3.23 Billion | ▲ +108.0% |
| 2016 | 0.02x | CN¥68.82 Million | CN¥46.01 Million | CN¥3.16 Billion | ▼ -83.5% |
| 2015 | 0.13x | CN¥369.57 Million | CN¥333.99 Million | CN¥2.81 Billion | ▼ -63.8% |
| 2014 | 0.36x | CN¥409.64 Million | CN¥392.58 Million | CN¥1.13 Billion | ▲ +518.1% |
| 2013 | -0.09x | CN¥-125.31 Million | CN¥-158.31 Million | CN¥1.44 Billion | ▼ -160.1% |
| 2012 | 0.14x | CN¥252.13 Million | CN¥221.57 Million | CN¥1.75 Billion | ▲ +1751.3% |
| 2011 | -0.01x | CN¥-16.69 Million | CN¥-108.30 Million | CN¥1.91 Billion | ▼ -106.4% |
| 2010 | 0.14x | CN¥217.89 Million | CN¥162.99 Million | CN¥1.58 Billion | ▼ -69.5% |
| 2009 | 0.45x | CN¥541.18 Million | CN¥447.82 Million | CN¥1.20 Billion | ▲ +6465.7% |
| 2008 | 0.01x | CN¥8.72 Million | CN¥-65.93 Million | CN¥1.27 Billion | ▼ -96.2% |
| 2007 | 0.18x | CN¥233.86 Million | CN¥191.10 Million | CN¥1.27 Billion | ▼ -19.3% |
| 2006 | 0.23x | CN¥262.87 Million | CN¥191.13 Million | CN¥1.16 Billion | ▼ -28.1% |
| 2005 | 0.32x | CN¥348.00 Million | CN¥313.04 Million | CN¥1.10 Billion | ▲ +96.2% |
| 2004 | 0.16x | CN¥133.38 Million | CN¥60.69 Million | CN¥828.09 Million | ▼ -68.9% |
| 2003 | 0.52x | CN¥267.11 Million | CN¥71.65 Million | CN¥516.46 Million | ▲ +14.2% |
| 2002 | 0.45x | CN¥182.81 Million | CN¥127.49 Million | CN¥403.72 Million | ▲ +315.0% |
| 2001 | 0.11x | CN¥50.15 Million | CN¥14.79 Million | CN¥459.59 Million | ▼ -52.5% |
| 2000 | 0.23x | CN¥122.94 Million | CN¥61.85 Million | CN¥534.74 Million | ▼ -35.0% |
| 1999 | 0.35x | CN¥101.66 Million | CN¥58.21 Million | CN¥287.56 Million | ▲ +38.9% |
| 1998 | 0.25x | CN¥61.55 Million | CN¥41.00 Million | CN¥241.76 Million | — |